According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031.
Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt